Preferred Label : Multiple congenital anomalies-hypotonia-seizures syndrome 2;
Symbol : MCAHS2;
CISMeF acronym : EIEE20; GPIBD4; MCAHS2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : GPIBD4; EIEE20; Epileptic encephalopathy, early infantile, 20; Glycosylphosphatidylinositol biosynthesis defect 4; Developmental and epileptic encephalopathy 20; DEE20;
Description : Multiple congenital anomalies-hypotonia-seizures syndrome-2 is an X-linked recessive
developmental disorder characterized by dysmorphic features, neonatal hypotonia, myoclonic
seizures, and variable congenital anomalies involving the central nervous, cardiac,
and urinary systems. Most affected individuals die in infancy (summary by Johnston
et al., 2012). For a discussion of genetic heterogeneity of MCAHS, see MCAHS1 (614080).;
Inheritance : X-linked recessive;
Molecular basis : Caused by mutation in the phosphatidylinositol glycan, class A gene (PIGA, 311770.0011);
Laboratory abnormalities : Increased serum alkaline phosphatase (in some patients);
Prefixed ID : #300868;
Origin ID : 300868;
UMLS CUI : C3275508;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)